Family History Of Alcohol Use Disorder As A Predictor Of Endogenous Pain Modulatory Function by White, Kyle Mackenzie
Syracuse University 
SURFACE at Syracuse University 
Theses - ALL 
Spring 5-22-2021 
Family History Of Alcohol Use Disorder As A Predictor Of 
Endogenous Pain Modulatory Function 
Kyle Mackenzie White 
Syracuse University 
Follow this and additional works at: https://surface.syr.edu/thesis 
 Part of the Psychology Commons 
Recommended Citation 
White, Kyle Mackenzie, "Family History Of Alcohol Use Disorder As A Predictor Of Endogenous Pain 
Modulatory Function" (2021). Theses - ALL. 503. 
https://surface.syr.edu/thesis/503 
This Thesis is brought to you for free and open access by SURFACE at Syracuse University. It has been accepted for 
inclusion in Theses - ALL by an authorized administrator of SURFACE at Syracuse University. For more information, 





Family history of alcohol use disorder (AUD) is frequently endorsed by chronic pain patients. 
Although individuals with a family history of AUD have demonstrated enhanced sensitivity to 
painful stimulation, we are not aware of any previous research that has examined clinically-
relevant endogenous pain modulation (i.e., capacity to inhibit or facilitate pain) in this 
population. The goal of this study was to test family history of AUD as a predictor of 
conditioned pain modulation, offset analgesia, and temporal summation among a sample of 
moderate-to-heavy drinkers. Participants (N = 235; 58.3% male; Mage = 34.3, SD = 12.3) were 
evaluated for family history of AUD at baseline (family history positive: n = 54; 59.3% white) 
and pain modulatory outcomes were assessed via quantitative sensory testing. Results indicated 
that participants with a family history of AUD (relative to those without) evinced a pro-
nociceptive pain modulation profile in response to experimental pain. Specifically, family history 
of AUD was associated with deficits in pain-inhibitory processes, which may help to explain the 
observed high rates of familial AUD in chronic pain patients. Exploratory analyses further 
suggested these effects may be driven by paternal AUD. The current findings suggest a family 
history of AUD may confer risk for AUD and chronic pain. Clinically, these data may inform 
treatment decisions for acute pain among individuals with a family history of AUD. 
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Family History of Alcohol Use Disorder as a Predictor of Endogenous Pain Modulatory Function 
Chronic pain is a significant and impactful condition, affecting an estimated 50 million 
U.S. adults (Dahlhamer et al., 2018) with costs in excess of $600 billion each year in healthcare 
expenses and lost productivity (Gaskin & Richard, 2012). Dysfunction in capacity to inhibit or 
facilitate pain (i.e., endogenous pain modulation) has been identified as an important mechanism 
in the development of chronically painful conditions (Ossipov, Morimura, & Porreca, 2014; van 
Wijk & Veldhuijzen, 2010; Yarnitsky, 2015), and individuals living with idiopathic pain 
syndromes (e.g., fibromyalgia, irritable bowel syndrome, temporomandibular disorder, etc.) have 
consistently demonstrated such dysfunction (Heymen et al., 2010; Kosek & Hansson, 1997; 
Maixner, Fillingim, Sigurdsson, Kincaid, & Silva, 1998). Pre-operative endogenous pain 
modulatory function among pain-free patients has also been shown to predict the incidence and 
severity of chronic post-operative pain (Wilder-Smith, Schreyer, Scheffer, & Arendt-Nielsen, 
2010; Yarnitsky et al., 2008). Thus, the capacity to modulate experimental pain has important 
bearing on chronic pain susceptibility, even among those currently unencumbered by pain. 
Although these prospective findings suggest a pathophysiological role for abnormal endogenous 
pain modulation in the development of chronic pain, factors that predispose individuals to 
differential pain modulatory function remain largely understudied. The current study is the first 
to examine family history of alcohol use disorder (AUD) as a predictor of endogenous pain 
modulation. 
Alcohol Use as a Risk Factor for Chronic Pain 
 The consumption of alcohol is known to confer acute analgesia (Thompson, Oram, 
Correll, Tsermentseli, & Stubbs, 2017). However, alcohol use may promote increased pain over 




onset of chronically painful conditions such as pancreatitis and alcohol neuropathy (Apte & 
Wilson, 2003; Sadowski & Houck, 2019). Chronic pain, often defined as pain that persists or 
recurs for more than three months (Treede et al., 2019), is also frequently observed in individuals 
seeking treatment for AUD (e.g., Boissoneault, Lewis, & Nixon, 2019; Sheu et al., 2008), with 
up to 73% endorsing moderate-to-severe past-month pain (Larson et al., 2007). Nationally 
representative longitudinal data further indicates that drinkers who ceased alcohol consumption 
over a three-year follow-up period demonstrated reduced bodily pain at the subsequent wave 
(Imtiaz, Loheswaran, Le Foll, & Rehm, 2018). 
 Long-term heavy alcohol use may contribute to negative pain outcomes via several 
pathways. Egli, Koob, and Edwards (2012) detailed evidence that alcohol dependence and 
chronic pain share overlapping neural substrates and proposed an allostatic load model in which 
repeated episodes of alcohol intoxication/withdrawal may result in pathological changes to 
reward and stress circuitry. This model suggests long-term heavy alcohol exposure may give rise 
to chronic pain, in part, through dysregulation of opioid systems involved with endogenous pain 
modulation. In contrast to acute alcohol consumption, which stimulates the release of opioid 
peptides (e.g., Mitchell et al., 2012), sustained heavy alcohol use is believed to result in a central 
opioid deficiency (Gianoulakis, 2001). Alcohol is also known to interact with several other 
neurotransmitter systems involved in endogenous pain modulation, including glutamate, GABA, 
and serotonin (Chastain, 2006; Ossipov, Dussor, & Porreca, 2010).  
Endogenous Pain Modulation 
Endogenous pain modulation is a broad term that encompasses the ways in which the 
central nervous system can inhibit or facilitate pain. The brain exerts bi-directional control of 




nociceptive signals (i.e., those pertaining to actual or potential tissue damage; IASP, 2008), 
primarily at the level of the spinal cord (Ossipov et al., 2010; Staud, 2013). Following injury or 
repeated noxious stimulation, secondary neurons in the dorsal horn can also undergo central 
sensitization (Latremoliere & Woolf, 2009), which is characterized as increased responsiveness 
of nociceptive neurons in the central nervous system to their normal or subthreshold afferent 
input (IASP, 2008). Preclinical evidence suggests that disruption of the inhibitory-facilitatory 
balance may lead to an enhanced pain state if facilitation predominates (e.g., Pertovaara, 1998). 
However, an efficient pain inhibitory system can protect against the manifestation of an 
enhanced pain state (e.g., Xu, Kontinen, & Kalso, 1999). 
In humans, quantitative sensory testing (QST) is a gold-standard approach to examining 
intermediate phenotypes relevant to chronic pain (Diatchenko, Fillingim, Smith, & Maixner, 
2013). QST is a psychophysical test methodology that can assess sensory nervous system 
function and identify deviations in pain perception and modulation (Diatchenko et al., 2013; 
Roldan & Abdi, 2015). Indeed, a number of dynamic test paradigms have been developed to 
activate and quantify pain inhibitory and facilitatory mechanisms. Assessment of both 
mechanisms enables characterization of individual pain modulation profiles, such that low-
efficiency inhibition and/or enhanced facilitation would indicate a pro-nociceptive profile, and 
efficient inhibition and/or unenhanced facilitation would indicate an anti-nociceptive profile 
(Yarnitsky, Granot, & Granovsky, 2014). Individuals with a pro-nociceptive pain modulation 
profile may therefore experience more severe pain and have a higher probability of developing 
chronic pain, relative to those with an anti-nociceptive pain modulation profile (Yarnitsky et al., 
2014). QST paradigms commonly used to establish pain modulation profiles include conditioned 




Conditioned pain modulation. CPM is a dynamic test paradigm used to assess a central 
mechanism that inhibits pain (Le Bars, Dickenson, & Besson, 1979a, 1979b; Yarnitsky, 2010). 
CPM is demonstrated through the reduction of pain ratings to a noxious experimental stimulus 
by application of a remote conditioning stimulus. This process has been described as a “pain 
inhibits pain” phenomenon and is mediated by spino-bulbo-spinal loops and higher-order 
cerebral mechanisms (Le Bars et al., 1979a, 1979b; Leone & Truini, 2019). Deficits in CPM 
efficiency have been observed in numerous chronic pain conditions, especially idiopathic pain 
syndromes (e.g., Heymen et al., 2010; King et al., 2009; Leonard et al., 2009; Potvin et al., 
2010). In an attempt to clarify whether reduced CPM efficiency was a causative factor or 
consequence of chronic pain, Yarnitsky and colleagues (2008) assessed CPM in pain-free 
patients prior to thoracotomy, and then evaluated chronic post-operative pain 6 - 12 months 
following surgery. Results indicated that CPM efficiency predicted both the incidence and 
severity of chronic post-operative pain (Yarnitsky et al., 2008). Similar results were 
demonstrated in a sample of patients receiving abdominal surgery (Wilder-Smith et al., 2010). 
Taken together, these findings suggest the capacity to modulate experimental pain translates 
directly to a clinical context, with less efficient CPM predisposing individuals to chronic pain.  
Offset analgesia. OA is a dynamic test paradigm used to assess a central pain-inhibitory 
mechanism (Grill & Coghill, 2002). OA is demonstrated through a disproportionately large 
reduction in pain ratings after an incremental decrease in the intensity of a noxious stimulus, and 
has been characterized as a temporal contrast mechanism for nociceptive information (Grill & 
Coghill, 2002; Yelle, Rogers, & Coghill, 2008). Absent or reduced OA has been observed in 
neuropathic pain (e.g., Niesters, Hoitsma, Sarton, Aarts, & Dahan, 2011; Niesters et al., 2014) 




Niesters, 2015; Szikszay, Adamczyk, Carvalho, May, & Luedtke, 2020). Despite both evoking 
pain inhibition, neuroimaging indicates that OA and CPM rely on distinct mechanisms (Nahman-
Averbuch et al., 2014). For example, the OA effect has been associated with activation of brain 
regions supporting descending pain modulation, whereas the CPM effect has been associated 
with reductions in brain activity in regions involved in afferent nociceptive processing (Nahman-
Averbuch et al., 2014). Moreover, OA and CPM can be differentially affected by 
pharmacological manipulations (e.g., opioid receptor antagonism), and preliminary evidence 
indicates unique relations with lifestyle factors, such as physical activity (King et al., 2013; 
Martucci, Eisenach, Tong, & Coghill, 2012; Naugle & Riley, 2014). Taken together, these results 
support the notion that OA and CPM reflect distinct features of endogenous pain inhibition 
(Hermans, Calders, et al., 2016). 
Temporal summation. TS is a dynamic test paradigm used to assess a central 
mechanism that facilitates pain (Price & Dubner, 1977). TS is demonstrated through the 
enhancement of pain ratings along the duration of a noxious stimulus or train of noxious stimuli, 
despite a fixed stimulus intensity (Granot, Granovsky, Sprecher, Nir, & Yarnitsky, 2006). This 
process is believed to reflect summation of C-fiber-mediated responses of dorsal horn neurons 
(Price & Dubner, 1977; Price, Mao, Frenk, & Mayer, 1994). The TS paradigm acts as a proxy for 
central sensitization, which is thought to contribute to an array of chronic pain conditions 
(Arendt‐Nielsen et al., 2018). Indeed, enhanced TS has been observed in those with post-herpetic 
neuralgia (e.g., Eide, Stubhaug, Bremnes, & Breivik, 1994), chronic low back pain (e.g., Owens 
et al., 2016), osteoarthritis (e.g., Finan et al., 2013), and fibromyalgia (e.g., Staud, Robinson, & 
Price, 2007), among others. Pre-operative TS in patients with osteoarthritis has also been shown 




(Izumi, Petersen, Laursen, Arendt-Nielsen, & Graven-Nielsen, 2017; Petersen, Arendt-Nielsen, 
Simonsen, Wilder-Smith, & Laursen, 2015).  
Acute Alcohol Effects on CPM 
 Acute analgesic properties of alcohol have long been observed (e.g., Mullin & Luckhardt, 
1934). However, the effects of alcohol on clinically-relevant pain modulatory processes have 
received little empirical attention. Initial data indicates that acute alcohol intoxication augments 
CPM efficiency but has no effect on TS (Horn-Hofmann, Capito, Wolstein, & Lautenbacher, 
2019), leading to the suggestion that alcohol analgesia may be a consequence of increased 
endogenous pain inhibition rather than reduced pain facilitation. Given the frequent endorsement 
of alcohol use for self-medication in the context of chronic pain (e.g., Riley & King, 2009), it has 
been further posited that deficient CPM may serve as a risk factor in the development of AUD 
among those with a greater vulnerability to pain (Horn-Hofmann et al., 2019). In the current 
study, we contend that a family history of AUD may also influence endogenous pain modulatory 
function, conferring risk for chronic pain.  
Family History of AUD 
 The potential for alcohol to alter pain processing through long-term or heavy use suggests 
covariation between individual drinking history and pain reactivity. Consistent with this notion, 
men with AUD, while sober, have demonstrated greater sensitivity to painful stimulation than 
controls (e.g., Brown & Cutter, 1977). However, research on the pain characteristics of those 
with AUD may confound the effects of protracted alcohol use with the effects of premorbid 
factors (Stewart, Finn, & Pihl, 1995). One means of circumventing this limitation involves 
studying healthy individuals at risk for developing AUD, such as those with a family history of 




virtue of several biopsychosocial influences, including genetics and familial modeling of 
drinking behavior (e.g., Cadoret, Cain, & Grove, 1980; Chipperfield & Vogel-Sprott, 1988; 
Cloninger, Bohman, & Sigvardsson, 1981; Dawson, Harford, & Grant, 1992).  
Family History of AUD and Pain 
 A family history of AUD is frequently reported by individuals with chronic pain (e.g., 
38% - 55%; Goldberg, Pachas, & Keith, 1999; Katon, Egan, & Miller, 1985; Pecukonis, 2004). 
Although there are several possible explanations for this relationship, there is reason to believe 
that family history of AUD may influence pain outcomes, irrespective of individual patterns of 
alcohol consumption. For example, FH+ individuals have demonstrated increased sensitivity to 
painful electrical stimulation, relative to controls with a negative family history of AUD (FH-; 
Stewart et al., 1995). Importantly, groups in this study were observed to be equivalent in their 
weekly consumption of alcohol, suggesting the heightened sensitivity to painful stimulation in 
FH+ individuals was more likely a premorbid factor than it was a consequence of drinking 
pattern (Stewart et al., 1995). The results of this investigation are consistent with research 
indicating that FH+ individuals have a tendency to hyper-react to environmental stressors, as 
indexed by cardiovascular autonomic nervous system measures, such as digital blood volume 
amplitude (e.g., Conrod, Pihl, & Ditto, 1995; Finn & Pihl, 1987). Indeed, the physiology 
underlying control of the cardiovascular system is believed to overlap with systems that 
modulate the perception of pain (Randich & Maixner, 1984), and the functional relationship 
between these systems appears to be altered in some chronic pain conditions (Bruehl & Chung, 





 Measures of family history of AUD are sometimes viewed as indices of genetic 
contribution. However, these measures are better conceptualized as indices of risk that represent 
a combination of biopsychosocial influences (Zucker, Ellis, & Fitzgerald, 1994). Considerable 
research has focused on the association between family history and AUD, yet less attention has 
been paid to pain. This is surprising given that several mechanisms likely contribute to both 
conditions (e.g., Yeung, Craggs, & Gizer, 2017).  
 Genetics and epigenetics. Twin studies suggest 43% - 53% of the variability in AUD 
and 25% - 50% of the variability in chronic pain are due to genetic factors (Nielsen, Knudsen, & 
Steingrimsdottir, 2012; Verhulst, Neale, & Kendler, 2015). Considering the large heritability 
estimates and significant neurobiological overlap (Egli et al., 2012), it is believed that some 
genetic variants may confer risk for both AUD and chronic pain (Yeung et al., 2017). A recently 
published review of genetic association studies underscores the possibility of shared genetic 
liability, and polymorphisms within genes involved in dopamine (e.g., ANKK1) and opioid (e.g., 
OPRM1) neurotransmitter systems were identified as having the strongest overlap with respect to 
AUD and chronic pain (Yeung et al., 2017). Pre-clinical studies using rodents selectively bred 
for divergent alcohol preferences have also demonstrated evidence of covariation between 
alcohol preference and pain reactivity (e.g., Chester, Price, & Froehlich, 2002; Kampov-Polevoy 
et al., 1996).  
 Alcohol and pain trajectories may also be influenced by heritable changes in gene 
expression that do not involve changes to DNA sequence (i.e., epigenetics; Wolffe & Guschin, 
2000). Exposure to environmental toxicants is one source of epigenetic effects (Bollati & 
Baccarelli, 2010). For example, alcohol consumption in fathers prior to conception is believed to 




& Champagne, 2011). Substantial evidence in support of this notion comes from animal studies 
in which genetics and the environment can be carefully controlled. For instance, Finegersh and 
Homanics (2014) exposed male mice to chronic alcohol or control conditions, mated them to 
alcohol-naïve females, and tested the adult offspring on several outcomes. Alcohol exposure was 
found to decrease DNA methylation at the Bdnf promoter of paternal germs cells and this hypo-
methylation persisted in the brains of male and female offspring. Alcohol-sired male offspring 
also demonstrated enhanced sensitivity to the anxiolytic and motor-stimulating effects of alcohol 
and showed increased Bdnf expression in the ventral tegmental area relative to control-sired male 
offspring (Finegersh & Homanics, 2014). Similarly, adult alcohol-sired rats (vs. control-sired 
rats) have demonstrated hormonal abnormalities, including lower levels of beta-endorphin, an 
opioid peptide believed to be involved in the descending inhibition of pain (Bäckryd, Ghafouri, 
Larsson, & Gerdle, 2014; Cicero et al., 1990; Sprouse-Blum, Smith, Sugai, & Parsa, 2010). 
Taken together, these results suggest that pre-conceptual alcohol consumption in men has the 
potential to induce biochemical and behavioral changes in their offspring that may affect alcohol 
use and pain outcomes.  
 Psychosocial influence. It is important to recognize that family history of AUD imparts 
influence beyond genetic effects. The family, as a social context, is thought to be capable of 
promoting the development and maintenance of AUD and pain (e.g., Mares, van der Vorst, 
Engels, & Lichtwarck-Aschoff, 2011; Roy, 1982; Violon & Giurgea, 1984). Children raised by 
parents with AUD may be particularly vulnerable, as their homes likely share an atmosphere of 
tension, anxiety, and unpredictability (Woititz, 1983). Certain parent-child interpersonal patterns 
have also been shown to influence alcohol and pain outcomes. For example, parental modeling 




future consumption (Ryan, Jorm, & Lubman, 2010), and solicitous parental responding to child 
pain (e.g., continuously attending to pain symptoms) has been associated with greater functional 
disability in children with chronic abdominal pain (Walker & Zeman, 1992). Parental AUD has 
also been linked to physical and sexual child abuse (e.g., Miller, Maguin, & Downs, 1997; 
Vogeltanz et al., 1999), which in turn has been associated with the experience of chronic pain 
(e.g., Drossman et al., 1990; Walsh, Jamieson, MacMillan, & Boyle, 2007).  
Family History as a Multifaceted Risk Factor 
There is reason to believe that family history of AUD may serve as a risk factor for AUD 
and chronic pain. Consistent with a reciprocal model of substance use and pain (Ditre, Zale, & 
LaRowe, 2019; Zale, Maisto, & Ditre, 2015), both conditions may interact synergistically, 
engendering the escalation of drinking and pain among FH+ individuals. However, more 
research is needed to develop the current understanding of family history of AUD as it relates to 
pain perception. Although heightened pain sensitivity has been observed among individuals with 
a family history of AUD, we are not aware of any research to date that has examined clinically-
relevant pain modulatory outcomes, such as CPM, OA, and TS, in this population.  
The Current Study 
The goal of the current study was to test whether endogenous pain modulatory processes 
(i.e., CPM, OA, and TS) differ as a function of family history of AUD among a sample of 
moderate-to-heavy drinkers who had not yet developed chronic pain. Analyses were conducted 
using data collected from a primary experimental study of bidirectional pain-alcohol effects 
(5R01AA024844). We hypothesized that a family history of AUD would be associated with a 
pro-nociceptive pain modulation profile. That is, participants with a family history of AUD 




greater facilitation (i.e., TS) to experimentally induced pain. Given that the effects of family 
history of AUD may vary depending on the relationship to affected relatives (e.g., fathers vs. 
mothers; Chassin, Curran, Hussong, & Colder, 1996), an exploratory aim was to compare the 
effects of paternal and maternal histories of AUD.  
Method 
Participants  
 Participants were recruited from the local community through newspaper and internet 
advertisements for a primary study examining bidirectional pain-alcohol effects. Prospective 
participants were screened by telephone to assess study eligibility. Criteria for inclusion were: 
(1) 21 - 65 years of age; and (2) classified as a moderate or heavy drinker as assessed by the 
Quantity-Frequency Variability Index (QFV; Cahalan, Cisin, & Crossley, 1969). Exclusion 
criteria included: (1) current acute or chronic pain; (2) current use of prescription pain 
medications; (3) any possibility of being pregnant; (4) self-reported history of or treatment for 
psychiatric or alcohol/other drug problems; (5) medical conditions that contraindicate the use of 
alcohol; or (6) chili pepper allergies. A total of 235 participants completed the baseline 
assessment and pain modulatory measures (see Figure 1).  
Measures and Materials 
 Family history of AUD. Participants were interviewed using an abridged version of the 
Family History Assessment Module (FHAM; Rice et al., 1995) that included items pertaining 
solely to alcohol use. The FHAM is a structured diagnostic interview used to assess DSM-III-R 
psychiatric disorders among relatives of the informant. Consistent with previous research (e.g., 
Curran et al., 1999), participants were queried about their biological parents, siblings, 




(e.g., “Has drinking ever caused any of your relatives to have problems with health, family, job, 
or police?”). For each positively screened relative, a corresponding Individual Assessment 
Module (IAM) was administered to assess DSM-III-R symptoms of alcohol abuse/dependence. 
The FHAM has demonstrated excellent specificity and moderate sensitivity for diagnosis of 
relatives’ alcohol dependence (Rice et al., 1995).  
The Feighner criteria for alcoholism was applied to each IAM, yielding either “definite 
diagnosis”, “probable diagnosis”, “unknown,” or “negative” codes (Feighner et al., 1972). 
Consistent with previous research (e.g., Curran et al., 1999; Stoltenberg et al., 1998), definite and 
probable diagnoses were collapsed. Family history positive (FH+) participants were defined as 
those with one or both parents with a history of AUD, whereas family history negative (FH-) 
participants were defined as those without a history of AUD in either parent. Emphasis was 
placed on parents for several reasons. Dichotomous measures that partition on the basis of 
parental AUD are among the most frequently employed in family history research (e.g., Heitzeg, 
Nigg, Yau, Zucker, & Zubieta, 2010; Nirenberg, Liepman, Begin, Maisto, & Liebermann, 1990; 
Vaidya et al., 2019). Parents are also uniquely positioned to influence pain outcomes in their 
offspring via genetic, epigenetic, and psychosocial effects (e.g., Denk & McMahon, 2012; 
Mogil, 2012; Palermo & Eccleston, 2009). For exploratory analyses, participants with histories 
of paternal (PH+) and maternal (MH+) AUD were examined separately. Participants without a 
history of AUD in either parent were deemed paternal/maternal history negative (i.e., FH-).  
Quantitative sensory testing apparatus. The Medoc Q-Sense CPM System (Medoc 
Ltd., Ramat Yishai, Israel) was used to deliver contact-heat pain via 30 x 30 mm Peltier-based 
thermodes. The thermodes have a temperature range of 16°C - 50°C. Depending on the particular 




visual analog scale (CoVAS). CoVAS anchor points ranging from 0 (no pain) to 100 (most 
intense pain imaginable) were provided. Details specific to each test are described below.  
Psychophysical parameters. Prior to assessment of endogenous pain modulatory 
processes, pain threshold and pain tolerance were assessed using a test of limits protocol (Geva, 
Pruessner, & Defrin, 2014). Six trials of stimuli were administered to the non-dominant forearm 
at 30-second intervals, with each stimulus increasing in temperature from 32°C at a rate of 1°C 
per second. For the first three trials, participants indicated when they first perceived the stimulus 
as painful (threshold) using the remote push-button response device. During the last three trials, 
participants indicated when they were no longer willing to tolerate the stimulus (tolerance) using 
the same response device. Following each response, the temperature was recorded and began to 
return to 32°C at a rate of 1°C per second. Temperatures recorded during the first and last three 
trials were averaged to generate mean threshold and tolerance values, respectively. These data 
were then used to compute the supra-threshold (i.e., the midpoint temperature between threshold 
and tolerance). Individual supra-thresholds were later used as destination temperatures in 
endogenous pain modulatory assessments. 
Conditioned pain modulation. We utilized a single test-stimulus protocol that has 
previously demonstrated favorable test-retest reliability (Granovsky, Miller-Barmak, Goldstein, 
Sprecher, & Yarnitsky, 2016). The test-stimulus thermode was applied to the volar surface of the 
non-dominant forearm and the conditioning-stimulus thermode was applied to the dominant 
upper arm. Individual supra-thresholds were used as destination temperatures for both the test- 
and conditioning-stimuli. Prior to CPM assessment, participants were instructed to make 
continuous pain ratings of the test-stimulus only using the CoVAS. The test-stimulus increases in 




plateaus for 45 seconds. Exactly 20 seconds into this sequence, the conditioning-stimulus 
increases in temperature from 32°C at a rate of 2°C per second until supra-threshold is reached, 
where it plateaus for 25 seconds. Both stimuli then return to 32°C at a rate of 1°C per second. 
The final CPM effect is then computed as the difference between mean pain ratings during the 
10-second epoch after the conditioning-stimulus reaches supra-threshold and the 10-second 
epoch preceding initiation of the conditioning-stimulus (i.e., CPM = CoVASTest-Stimulus + Conditioning-
Stimulus - CoVASTest-Stimulus). Thus, evidence of pain inhibition is denoted by negative values.  
 Offset analgesia. OA protocols typically involve pain ratings during a contiguous three-
temperature stimulus sequence (e.g., 49°C, 50°C, 49°C), where the OA effect is characterized by 
a disproportionately large reduction in pain after an incremental decrease in the temperature of 
the stimulus (Grill & Coghill, 2002). We employed the same approach, using individual supra-
thresholds as the maximum temperature reached during a three-temperature stimulus sequence. 
The stimulus thermode was applied to the volar surface of the non-dominant forearm. Prior to 
OA assessment, participants were instructed to make continuous pain ratings of the stimulus 
using the CoVAS. During the first sequence, the stimulus increases in temperature from 32°C at 
a rate of 2°C per second until reaching 1°C below supra-threshold, where it plateaus for 5 
seconds (T1). The stimulus then increases in temperature at a rate of 1°C per second until supra-
threshold is reached, where it plateaus for 5 seconds (T2). The stimulus then decreases in 
temperature at a rate of 1°C per second until reaching 1°C below supra-threshold, where it 
plateaus for 20 seconds (T3). The stimulus then returns to 32°C at a rate of 1°C per second. The 
final OA effect is then computed as the difference between the maximum pain rating during the 
T2 epoch and the minimum pain rating during the T3 epoch (i.e., OA = CoVASMaxT2 - 




 Temporal summation. TS protocols utilize repetitive-phasic or tonic pain stimuli. Here, 
we used a tonic heat stimulus protocol, which, relative to repetitive-phasic heat stimulus 
protocols, is believed to evoke a shared mechanism of central pain modulation (Granot et al., 
2006). The stimulus thermode was applied to the volar surface of the non-dominant forearm. 
Prior to TS assessment, participants were instructed to make continuous pain ratings of the 
stimulus using the CoVAS. The stimulus increases in temperature from 32°C at a rate of 1°C per 
second until supra-threshold is reached, where it plateaus for 1 minute. The stimulus then returns 
to 32°C at a rate of 1°C per second. The final TS effect is then computed as the difference 
between the last pain rating during the 1-minute epoch and the first pain rating during the 1-
minute epoch (i.e., TS = CoVASLast - CoVASFirst). Thus, evidence of pain facilitation is denoted 
by positive values.  
 Alcohol consumption pattern. The Quantity-Frequency Variability Index (QFV; 
Cahalan et al., 1969) was used to assess patterns of alcohol consumption. Participants reported, 
over the previous three months, the types of alcoholic beverages they drank, their frequency of 
consumption, and how much they usually drank during these occasions. Per inclusion criteria, 
alcohol consumption patterns in the current sample were classified as moderate or heavy. The 
QFV has shown good reliability and validity (Cahalan et al., 1969).   
 Sociodemographic characteristics. Participants reported a range of sociodemographic 
characteristics, including age, race, ethnicity, biological sex, education, marital status, and annual 
income. 
Procedure  
 After telephone screening, eligible participants were scheduled for two study visits, no 




at least 24 hours prior to their appointments. Participants provided informed consent and 
completed measures to verify eligibility at the first visit. During the first visit, eligible 
participants also completed self-report questionnaires and a structured interview to assess family 
history of AUD. Given that procedures were counterbalanced across sessions in the parent study, 
participants completed the QST assessment during either their first or second appointment. Pain 
modulatory assessments were conducted in in the following order: (1) CPM; (2) OA; (3) TS. 
Participants were compensated up to $106 for completing the first visit and up to $132 for 
completing the second visit. Procedural details are shown in Figure 2.  
Power Analysis 
 An a priori power analysis was performed using the program G*Power (Faul, Erdfelder, 
Lang, & Buchner, 2007) to estimate the sample size necessary for the current study. This 
analysis was based on data from Stewart et al. (1995), comparing pain sensitivity between FH+ 
and FH- participants (N = 81). Considering the dearth of research investigating family history of 
AUD in relation to pain outcomes, this reference was selected for effect size estimation. Using 
Cohen’s (1988) criteria, the effect size in this study was medium (f = .31). Thus, with an alpha 
value of 0.05 and power level of 0.80, the required sample size was approximately 70 (n = 35 per 
group).  
Data Analytic Plan  
 Analyses were conducted using SPSS Statistics 27 (IBM SPSS Statistics, 2012). First, 
continuous variables were compared with a t-test and categorical variables with the chi-square 
test for independent groups (i.e., FH+ vs. FH-). Mean and standard deviations were computed for 




variables. An alpha value of 0.05 was used as the criterion for statistical significance. 
Preliminary analyses were also conducted to ensure no violation of parametric assumptions.  
For the primary aim, we tested the effects of family history of AUD (i.e., FH+ vs. FH-) 
on CPM, OA, and TS using Multivariate Analysis of Covariance (MANCOVA). Multivariate 
analysis, as opposed to separate univariate analyses, was selected as CPM, OA, and TS tend to 
be correlated (e.g., Honigman, Yarnitsky, Sprecher, & Weissman-Fogel, 2013; Nahman-
Averbuch et al., 2011) and are conceptually linked in that they all reflect endogenous pain 
modulatory processes. When outcomes are correlated, MANCOVA affords greater statistical 
power and has the advantage of limiting the family-wise error rate relative to separate univariate 
analyses (Bray & Maxwell, 1985; Tabachnick, Fidell, & Ullman, 2007). Covariates selected a 
priori included age and biological sex, given previously documented associations with CPM 
(e.g., Hermans, Van Oosterwijck, et al., 2016), OA (e.g., Nahman-Averbuch et al., 2016; Naugle, 
Cruz-Almeida, Fillingim, & Riley, 2013), and TS (e.g., Edwards & Fillingim, 2001; Robinson, 
Wise, Gagnon, Fillingim, & Price, 2004). Because we were interested in testing the effects of 
family history of AUD above and beyond that of alcohol consumption pattern, QFV category 
was also included as a covariate. For the exploratory aim, the analysis above was repeated 
comparing individuals who endorsed histories of paternal vs. maternal AUD separately to more 
specifically examine parental contribution. To conserve cell sizes, participants with histories of 
AUD in both parents were deemed PH+ and MH+.  
Outliers can have detrimental effects on statistical analyses by increasing error variance 
and reducing power, decreasing normality, and increasing the odds of making Type I and Type II 
errors (e.g., Osborne & Overbay, 2004). Psychophysiological measures are especially prone to 




example, QST measures events occurring outside the participant’s body (i.e., movements of the 
CoVAS) that are reflective of internal events (i.e., pain perception). Thus, the signal is subject to 
some distortion, periodically creating artifacts that should be removed prior to statistical analysis 
(Cacioppo et al., 2007). For these reasons, we detected and excluded cases ± 3 median absolute 
deviations from each outcome. This is a conservative method for handling outliers that has been 
recommended by researchers and statisticians (e.g., Kannan, Manoj, & Arumugam, 2015; Leys, 
Ley, Klein, Bernard, & Licata, 2013). Twenty-three outliers were excluded from the primary 
analysis (FH+: n = 8; FH-: n = 15). For the exploratory aim, 19 outliers were excluded from the 
paternal analysis (PH+: n = 4; FH-: n = 15) and 20 outliers were excluded from the maternal 
analysis (MH+: n = 5; FH-: n = 15). Sensitivity analyses were performed to examine whether 
results differed as a consequence of outlier exclusion.  
Results 
Participant Characteristics 
 Participants included 235 moderate-to-heavy drinkers (66% heavy; Mage = 34.3, SD = 
12.3). The sample was predominantly male (58.3%), non-Hispanic (91.9%), white (60%), and 
single (72.3%). Approximately 40% of participants reported a household income of less than 
$20,000 per year and having a high school degree or less in terms of education. Structured 
diagnostic interviews (FHAM) revealed that 23% of the sample was FH+ (n = 54). Among the 
FH+ participants, 9 reported history of AUD in both father and mother, 29 reported only paternal 
history of AUD, and 16 reported only maternal history of AUD. No differences were observed 
between FH+ and FH- groups with regard to any sociodemographic variables. Additional 
sociodemographic, family history, and drinking pattern data are presented in Table 1. 




  Preliminary testing of parametric assumptions revealed that the data was normally 
distributed, as assessed by inspection of Q-Q plots and skewness and kurtosis; there were no 
multivariate outliers, as assessed by Mahalanobis distance (p > .001); there were linear 
relationships between outcome variables for each group, as assessed by scatterplot; there was no 
multicollinearity (|r| < .9); and there was homogeneity of variance-covariance matrices, as 
assessed by Box’s M test (p = .014). There was also evidence of a linear relationship between the 
covariate age and each of the outcome variables for FH+ and FH- participants, as assessed by 
inspection of scatterplots. Additionally, there was homogeneity of regression slopes, as assessed 
by the interaction term between age and family history group (F [3, 204] = .744, p = .527).  
Family History of AUD and Endogenous Pain Modulatory Function 
Consistent with expectation, MANCOVA indicated a statistically significant difference 
between FH+ and FH- participants on the combined dependent variable (F [3, 205] = 2.785, p = 
.042; Wilks’ Λ = .961; partial η2 = .039), accounting for nearly 4% of the variance in 
endogenous pain modulatory function. The effect of the covariate age was also significant (F [3, 
205] = 3.441, p = .018; Wilks’ Λ = .952; partial η2 = .048), whereas biological sex and QFV 
category were not (ps > .05). Univariate follow-up tests revealed a significant difference in OA 
scores between FH+ and FH- participants (F [1, 207] = 7.747, p = .006, partial η2 = .036), with 
adjusted means of 21.00 (95% CI = 12.92, 29.07) and 33.70 (95% CI = 29.32, 38.08), 
respectively (Figure 3). No differences were observed for CPM (F [1, 207] = 2.320, p = .129, 
partial η2 = .011) or TS scores (F [1, 207] < 0.001, p = .992, partial η2 < .001). The adjusted 
means for all dependent variables are presented in Table 2. 




Exploratory MANCOVA indicated a significant difference between PH+ and FH- 
participants on the combined dependent variable (F [3, 193] = 2.760, p = .043; Wilks’ Λ = .959; 
partial η2 = .041). Again, the covariate age was significant (F [3, 193] = 3.921, p = .010; Wilks’ 
Λ = .943; partial η2 = .057), whereas biological sex and QFV category were not (ps > .05). 
Univariate follow-up tests revealed significant differences in CPM (F [1, 195] = 5.287, p = .023, 
partial η2 = .026) and OA scores (F [1, 195] = 5.470, p = .020, partial η2 = .027) between PH+ 
and FH- participants, but not TS scores (F [1, 195] = 0.161, p = .688, partial η2 = .001). 
Participants in the PH+ group demonstrated higher (i.e., less efficient) CPM scores and lower 
OA scores relative to FH- participants, with adjusted mean differences of 6.09 (95% CI = 0.87, 
11.31) and -12.43 (95% CI = -22.91, -1.95), respectively (Figures 4 and 5). In contrast to the 
paternal MANCOVA, no differences were observed between MH+ and FH- participants on the 
combined dependent variable (F [3, 179] = .884, p = .451; Wilks’ Λ = .985; partial η2 = .015). 
The adjusted means for exploratory subgroup analyses are presented in Tables 3 and 4. 
Sensitivity Analyses 
 Sensitivity analyses revealed that the primary analysis comparing FH+ vs. FH- 
participants on the combined dependent variable was no longer statistically significant when 
outliers were included (F [3, 228] = .970, p = .073; Wilks’ Λ = .970; partial η2 = .030). Inclusion 
of outliers did not influence the pattern of results for the paternal (i.e., PH+ vs. FH-; F [3, 212] = 
.946, p = .008; Wilks’ Λ = .946; partial η2 = .054) and maternal (i.e., MH+ vs. FH-; F [3, 199] = 
.249, p = .862; Wilks’ Λ = .996; partial η2 = .004) exploratory analyses. Significant univariate 
differences between PH+ and FH- participants were still detected for CPM and OA (ps < .05). 




OA scores relative to FH- participants, with adjusted mean differences of 10.21 (95% CI = 3.20, 
17.22) and -11.82 (95% CI = -22.02, -1.63), respectively.  
Discussion 
 The current study represents the first demonstration of altered pain modulatory function 
among individuals with a family history of AUD. As hypothesized, moderate-to-heavy drinkers 
with a family history of AUD (relative to those without) evinced a pro-nociceptive pain 
modulation profile in response to experimental pain testing. Specifically, family history of AUD 
was associated with deficits in pain-inhibitory processes, such as OA and CPM. Here, low-
efficiency pain inhibition places participants on the pro-nociceptive end of the clinical spectrum 
between pro- and anti-nociception (Yarnitsky et al., 2014). Group differences were also observed 
after controlling for the variance attributable to QFV category, suggesting the effects of family 
history were independent of alcohol consumption pattern. Further, the exploratory analyses 
suggest these effects may be driven by paternal history of AUD.  
 Collectively, these findings contribute to a nascent literature implicating family history of 
AUD in pain perception and potential for developing chronic pain. Stewart and colleagues 
(1995) documented heightened pain sensitivity among FH+ participants using aversive electrical 
stimulation and static pain intensity rating scales. The current study expands upon this finding by 
providing evidence that family history of AUD may also influence dynamic and clinically-
relevant pain modulatory processes. These results might help to clarify the high rates of familial 
AUD observed among chronic pain patients (Goldberg et al., 1999; Katon et al., 1985; 
Pecukonis, 2004). Indeed, previous studies have underscored the pathophysiological role of 




2010; Yarnitsky et al., 2008). Family history of AUD may therefore confer risk for chronic pain 
via its effects on endogenous pain-inhibitory systems. 
The current study design prevents mechanistic conclusions from being drawn regarding 
the associations between family history of AUD and pain modulatory outcomes. However, some 
insight may be gleaned from prior research. For example, certain genetic polymorphisms (e.g., 
within the serotonin-transporter-linked polymorphic region in SLC6A4) have been implicated in 
both AUD (e.g., Feinn, Nellissery, & Kranzler, 2005) and endogenous pain modulation (e.g., 
Lindstedt et al., 2011). To our knowledge, these relations have not been tested under one 
overarching paradigm, but they do emphasize the possibility of common genetic liability. It is 
also worth noting that OA was the dynamic test paradigm most strongly associated with family 
history of AUD. This is perhaps unsurprising given that OA likely evaluates more brain derived 
pain modulation than CPM and TS (Hermans, Calders, et al., 2016; Price & Dubner, 1977), and a 
substantial literature indicates differences in brain structure and function between FH+ and FH- 
individuals (e.g., Cservenka, 2016). Additionally, exploratory analyses intended to examine 
potential differences in parental contribution emphasized the role of fathers. In drawing from the 
extant animal literature, one could invoke epigenetic effects of pre-conceptual alcohol exposure 
in males. For instance, adult alcohol-sired rats have exhibited lower levels of beta-endorphin in 
the hypothalamus relative to control-sired rats (i.e., those whose fathers were not chronically 
exposed to alcohol prior to mating; Cicero et al., 1990). The neurobiology subserving the 
descending modulation of pain originates in the hypothalamus, among other key brain regions 
(Ossipov et al., 2010; Puopolo, 2019). In response to pain, hypothalamic release of beta-
endorphin in the periaqueductal gray region inhibits the release of GABA, facilitating 




al., 2010). In the context of the current study, paternal history of AUD may have been associated 
with reduced endogenous pain inhibition, in part, due to lower beta-endorphin levels. Supporting 
this notion, prior clinical research has found that patients with chronic neuropathic pain have 
lower levels of beta-endorphin in their cerebrospinal fluid compared to healthy controls (Bäckryd 
et al., 2014).  
 Strengths of the current study include the relatively large sample size, recruitment of 
drinkers from the general population, and use of established QST pain assessment methods. 
However, several limitations should be noted. First, the sample was comprised of moderate-to-
heavy drinkers with no indication of AUD. Future research would benefit from testing these 
relations among infrequent-to-light drinkers, abstainers, and those with AUD. Despite 
statistically controlling for QFV category in our models, alcohol consumption patterns were 
restricted to those classified as moderate or heavy. It is therefore unclear whether the effects of 
family history of AUD would be consistent across individuals with varied drinking patterns. 
Second, our power analysis estimated a required sample size of 70 (n = 35 per group). Thus, the 
exploratory subgroup analysis comparing MH+ vs. FH- participants was likely underpowered 
(MH+: n = 20; FH-: n = 166), increasing the likelihood of a false negative finding (Burke, 
Sussman, Kent, & Hayward, 2015). Third, although family history interviews have been found to 
be a valid source of diagnostic information, sensitivity may be diminished when relying on a 
single informant (Andreasen, Rice, Endicott, Reich, & Coryell, 1986; Rice et al., 1995). Fourth, 
additional research will be needed to determine whether differential pain modulatory function in 
individuals with a family history of AUD predicts the development of chronic pain. Finally, 




current findings and help clarify the conflicting literature on racial/ethnic differences in 
experimental pain reactivity (Peacock & Patel, 2008).  
 The current analyses provide evidence that family history of AUD may influence 
clinically-relevant pain modulatory outcomes. A deeper understanding of this relationship may 
eventually promote early identification and treatment of individuals at risk for chronic pain. 
Indeed, family history assessment is believed to be the most cost-effective means of screening 
individuals at risk for certain disorders, especially for those with a strong genetic basis (Bennett, 
2010). Increased awareness of the connection between family history of AUD and pain may also 
inform treatment decisions for acute pain among FH+ individuals. For example, healthcare 
providers might elect to use more comprehensive and interdisciplinary pain management 
approaches (e.g., multimodal analgesia, cognitive-behavioral therapy, etc.) in efforts to prevent 
the development of chronic pain among those with a family history of AUD (McGreevy, Bottros, 
& Raja, 2011).  
 In conclusion, results of the current study indicate altered pain modulatory function 
among individuals with a family history of AUD. These findings suggest that individuals with a 
family history of AUD may represent a population that is particularly vulnerable to the 











Family History of AUD 
 
QFV Category 
FH- FH+ Moderate Heavy 
 n (%) n (%) n (%) n (%) n (%) 
Gender      
   Male 137 (58.3%) 108 (59.7%) 29 (53.7%) 41 (51.3%) 96 (61.9%) 
   Female 98 (41.7%) 73 (40.3%) 25 (46.3%) 39 (48.8%) 59 (38.1%) 
Ethnicity      
   Non-Hispanic 216 (91.9%) 168 (92.8%) 48 (88.9%) 72 (90.0%) 144 (92.9%) 
Race      
   White 141 (60.0%) 109 (60.2%) 32 (59.3%) 54 (67.5%) 87 (56.1%) 
   Black 86 (36.6%) 68 (37.6%) 18 (33.3%) 23 (28.8%) 63 (40.6%) 
   Other 8 (3.4%) 4 (2.2%) 4 (7.4%) 3 (3.8%) 5 (3.2%) 
Marital Status      
   Single 170 (72.3%) 130 (71.8%) 40 (74.1%) 53 (66.3%) 117 (75.5%) 
   Married 31 (13.2%) 25 (13.8%) 6 (11.1%) 14 (17.5%) 17 (11.0%) 
   Separated/Divorced/Widowed 34 (14.5%) 26 (14.4%) 8 (14.8%) 13 (16.3%) 21 (13.5%) 
Education      
   Did Not Graduate High School 12 (5.1%) 12 (6.6%) 0 (0.0%) 0 (0.0%)** 12 (7.7%)** 
   High School Graduate 78 (33.2%) 57 (31.5%) 21 (38.9%) 16 (20.0%)** 62 (40.0%)** 
   Some College or Greater 145 (61.7%) 112 (61.9%) 33 (61.1%) 64 (80.0%)** 81 (52.3%)** 
Annual Household Income      
   Less Than $10,000 60 (25.5%) 50 (27.6%) 10 (18.5%) 11 (13.8%)* 49 (31.6%)* 
   $10,000 - $19,999 41 (17.4%) 28 (15.5%) 13 (24.1%) 13 (16.3%)* 28 (18.1%)* 
   $20,000 - $29,999 43 (18.3%) 33 (18.2%) 10 (18.5%) 20 (25.0%)* 23 (14.8%)* 
   $30,000 - $39,999 24 (10.2%) 19 (10.5%) 5 (9.3%) 11 (13.8%)* 13 (8.4%)* 
   Greater Than $40,000 67 (28.5%) 51 (28.2%) 16 (29.6%) 25 (31.3%)* 42 (27.1%)* 
 M (SD) M (SD) M (SD) M (SD) M (SD) 
Age 34.34 (12.30) 34.32 (12.51) 34.41 (11.70) 32.84 (11.79) 35.12 (12.52) 
Note. FH- = family history negative (those without a history of AUD in either parent); FH+ = family history positive 
(those having one or both parents with a history of AUD); QFV = Quantity-Frequency Variability Index; * p < .05; 






Adjusted Means of Pain Modulatory Outcomes as a Function of Family History of AUD 
 FH- FH+  
 M (SE) M (SE) F (1, 207) 
Conditioned Pain Modulation -4.41 (1.12) -0.91 (2.06) 2.32 
Offset Analgesia 33.70 (2.22) 21.00 (4.10) 7.75** 
Temporal Summation 8.35 (2.08) 8.40 (3.83) <0.01 
Note. AUD = alcohol use disorder; FH- = family history negative (those without a history of AUD in either parent); 




Adjusted Means of Pain Modulatory Outcomes as a Function of Paternal History of AUD 
 
 FH- PH+  
 M (SE) M (SE) F (1, 195) 
Conditioned Pain Modulation -4.35 (1.14) 1.74 (2.47) 5.29* 
Offset Analgesia 33.70 (2.28) 21.27 (4.95) 5.47* 
Temporal Summation 8.53 (2.15) 10.53 (4.66) 0.16 
Note. AUD = alcohol use disorder; FH- = family history negative (those without a history of AUD in either parent); 




Adjusted Means of Pain Modulatory Outcomes as a Function of Maternal History of AUD 
 
 FH- MH+  
 M (SE) M (SE) F (1, 181) 
Conditioned Pain Modulation -4.20 (1.11) -5.44 (3.03) 0.15 
Offset Analgesia 33.31 (2.30) 23.97 (6.29) 1.92 
Temporal Summation 8.49 (2.16) 9.95 (5.92) 0.05 
Note. AUD = alcohol use disorder; FH- = family history negative (those without a history of AUD in either parent); 
































Figure 1. Inclusion of Participants. 
  
Screened ineligible at first 
study visit  
(n = 116)  
Did not complete Family 
History Assessment 
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Figure 3. Offset Analgesia Scores as a Function of Family History of AUD. 
Note. AUD = alcohol use disorder; FH+ = family history positive (those with one or both parents 
with a history of AUD); FH- = family history negative (those without a history of AUD in either 
parent); means statistically adjusted for age, biological sex, and drinking pattern (QFV category); 





























Figure 4. Conditioned Pain Modulation Scores as a Function of Paternal History of AUD. 
Note. AUD = alcohol use disorder; PH+ = paternal history positive (those with a father with a 
history of AUD); FH- = family history negative (those without a history of AUD in either 
parent); means statistically adjusted for age, biological sex, and drinking pattern (QFV category); 



























Figure 5. Offset Analgesia Scores as a Function of Paternal History of AUD. 
Note. AUD = alcohol use disorder; PH+ = paternal history positive (those with a father with a 
history of AUD); FH- = family history negative (those without a history of AUD in either 
parent); means statistically adjusted for age, biological sex, and drinking pattern (QFV category); 






Family History Assessment Module (FHAM) - Screener 
I would like to ask you some questions about your children, parents, sisters/brothers, and 
grandparents that you just mentioned in the family tree. 
 
FOR EACH RELATIVE MENTIONED, RECORD NAME AND RELATIONSHIP. 
 
1. Has drinking ever caused any of your relatives to have  REL:      
    problems with health, family, job, or police?    
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
 
2. Have any of your relatives ever talked to a doctor or a  REL:      
    counselor about any problems with alcohol? 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
 
3. Have any of your relatives ever been hospitalized   REL:      
    because of alcohol problems? 




         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
         REL:      
 
 
IF ANY RELATIVE MENTIONED IN Q. 2-3 ONLY, GO BACK AND RE-ASK 
APPROPRIATE SCREENING QUESTION (Q. 1). OTHERS CONTINUE. 
 
4. So, none of the following relatives, that is… (LIST RELATIVES NOT RECORDED IN Q. 
1, 2, 3), had any problems with alcohol? 
 
ADMINISTER AN INDIVIDUAL ASSESSMENT MODULE (IAM) FOR EACH 







FHAM - Individual Assessment Module (IAM) 
 
RELATIVE:      
 
 Would you say that you know/knew him/her well? 
         No Yes Unsure 
 
 When was the last time you had any contact with him/her? 
          Month/Year    
 
 Is this relative living? 
     No Yes Unsure 
 
Because of drinking, did your (RELATIVE) ever have problems, such as: 
            N Y U 
 1. using alcohol in larger amounts or over a longer period than s/he intended? 1  5  9 
 2. being unable to stop or cut down on drinking?     1  5  9 
 3. spending a lot of time drinking or being hung over?    1  5  9 
 4. being unable to work, go to school or take care of household responsibilities? 1  5  9 
 5. being high from drinking when s/he could get hurt?    1  5  9 
 6. having accidental injuries?        1  5  9 
 7. reducing or giving up important activities?     1  5  9 
 8. objections from family or friends, or at work or school?    1  5  9 
 9. having a legal problem (DWIs, arrests)?      1  5  9 
          10. having blackouts?         1  5  9 
          11. going on binges or benders, drinking 2 or more days without sobering up? 1  5  9 
          12. physical health problems (liver disease, pancreatitis)?    1  5  9 
          13. emotional or psychological problems (uninterested, depressed,  
     suspicious/paranoid, having strange ideas)?     1  5  9 
          14. withdrawal symptoms (shakes, seizures/convulsions, DTs)?   1  5  9 
          15. needing to drink a great deal more in order to get an effect, or finding that 
     s/he could no longer get drunk on the amount s/he used to drink?  1  5  9 
          16. any kind of treatment of hospitalization?      1  5  9 
          17. making rules to control drinking (never drinking alone, never drinking 
     before 5 p.m.), drinking before breakfast, or drinking non-beverage 
     alcohol like vanilla extract, cough syrup, or rubbing alcohol?   1  5  9 
          18. trouble at work or school or getting into fights while drinking?   1  5  9 
          19. losing friends because of his/her drinking, considering him/herself an 





IF 3 OR MORE 5’s CODED IN Q. 1-19, CONTINUE. OTHERS CONCLUDE. 
 
20. Did (RELATIVE) have a period of a month or more when 3 or more of these experiences 
occurred together? 
        NO (SKIP TO 21)  1 
        YES    5 
        UNSURE (SKIP TO 21) 9 
 
a. How old was (RELATIVE) the first/last time (he/she) had three or more of these experiences 
occurring within a period lasting a month or longer? 
        AGE ONSET: 
        AGE RECOVERED: 
 
21. OMIT PHRASE IN BRACKETS IF Q. 20 CODED NO. 
[Since (RELATIVE) developed problems at about age (AGE ONSET ABOVE),] was 
there ever a period of three months or longer when (RELATIVE) did not have anything 
to drink? 
       NO (CONCLUDE)  1 
       YES    5 
       UNSURE (CONCLUDE) 9 
 
a. How old was (RELATIVE) when these periods occurred? 
         AGE to AGE 
 
        Period 1 ___ to ___ 
        Period 2 ___ to ___ 
        Period 3 ___ to ___ 
        Period 4 ___ to ___ 












Definite diagnosis: one or more items coded 5 in at least three of the following four groups: 
 
 I: 10, 11, 12, 14 
 II: 2, 17 
 III: 9, 18 
 IV: 8, 19 
 
Probable diagnosis: two items coded 5 in two different groups, from the groups listed above 
Unknown: combination of 5s and 9s are not enough to meet above two thresholds 
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